The clinical significance of the prognostic nutritional index in very elderly patients over 80 years of age with diffuse large B-cell lymphoma

Ann Hematol. 2020 May;99(5):1153-1155. doi: 10.1007/s00277-020-04012-7. Epub 2020 Apr 8.

Authors

Erina Hamada¹, Ogura Shinji¹, Yuriko Nishiyama-Fujita¹, Masahiro Akiimoto¹, Tomohiko Tanigawa¹, Chisako Ito¹, Aki Sakurai¹, Yoshinobu Aisa¹, Tomonori Nakazato²

Affiliations

¹ Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.
² Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan. n-tomo@eurus.dti.ne.jp.

PMID: 32270216
DOI: 10.1007/s00277-020-04012-7

No abstract available

Publication types

Letter

MeSH terms

Aged, 80 and over
Biomarkers
Combined Modality Therapy
Humans
Kaplan-Meier Estimate
Lymphoma, Large B-Cell, Diffuse / diagnosis
Lymphoma, Large B-Cell, Diffuse / epidemiology*
Lymphoma, Large B-Cell, Diffuse / therapy
Nutrition Assessment*
Prognosis
Retrospective Studies

Substances

Biomarkers